INTEGRA LIFESCIENCES HOLDINGS CORP Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities
INTEGRA LIFESCIENCES HOLDINGS CORP (IART) reported Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities of 0 shares for the 12-month period ending 2018-12-31, per its 10-K filed 2019-02-26.
Discontinued › Income Statement › Earnings Per Share
us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities · last filed 2019-02-26
- INTEGRA LIFESCIENCES HOLDINGS CORP incremental common shares attributable to dilutive effect of conversion of debt securities for the quarter ending 2017-09-30 was 0.00 shares, a 100.00% decline year-over-year.
- INTEGRA LIFESCIENCES HOLDINGS CORP incremental common shares attributable to dilutive effect of conversion of debt securities for the quarter ending 2017-06-30 was 0.00 shares, a 100.00% decline year-over-year.
- INTEGRA LIFESCIENCES HOLDINGS CORP incremental common shares attributable to dilutive effect of conversion of debt securities for the quarter ending 2017-03-31 was 0.00 shares, a 100.00% decline year-over-year.
- INTEGRA LIFESCIENCES HOLDINGS CORP incremental common shares attributable to dilutive effect of conversion of debt securities for the quarter ending 2016-09-30 was 3.18M shares.
- INTEGRA LIFESCIENCES HOLDINGS CORP incremental common shares attributable to dilutive effect of conversion of debt securities for fiscal 2018 was 0.00 shares.
- INTEGRA LIFESCIENCES HOLDINGS CORP incremental common shares attributable to dilutive effect of conversion of debt securities for fiscal 2017 was 0.00 shares, a 100.00% decline from fiscal 2016.
- INTEGRA LIFESCIENCES HOLDINGS CORP incremental common shares attributable to dilutive effect of conversion of debt securities for fiscal 2016 was 2.30M shares, a 149.02% increase from fiscal 2015.
- INTEGRA LIFESCIENCES HOLDINGS CORP incremental common shares attributable to dilutive effect of conversion of debt securities for fiscal 2015 was 922.00K shares.
| Period end | Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities 3 month | Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities 3 month as first filed | Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities 6 month | Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities 6 month as first filed | Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities 9 month | Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities 9 month as first filed | Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities 12 month | Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2018-12-31 | 0.00 shares 10-K · filed 2019-02-26 | |||||||
| 2017-12-31 | 0.00 shares 10-K · filed 2019-02-26 | |||||||
| 2017-09-30 | 0.00 shares 10-Q · filed 2017-10-26 | 0.00 shares 10-Q · filed 2017-10-26 | ||||||
| 2017-06-30 | 0.00 shares 10-Q · filed 2017-07-26 | 0.00 shares 10-Q · filed 2017-07-26 | ||||||
| 2017-03-31 | 0.00 shares 10-Q · filed 2017-04-26 | |||||||
| 2016-12-31 | 2.30M shares 10-K · filed 2019-02-26 | |||||||
| 2016-09-30 | 3.18M shares 10-Q · filed 2017-10-26 | 2.59M shares 10-Q · filed 2016-10-28 | 2.26M shares 10-Q · filed 2017-10-26 | 1.61M shares 10-Q · filed 2016-10-28 | ||||
| 2016-06-30 | 2.29M shares 10-Q · filed 2017-07-26 | 1.60M shares 10-Q · filed 2016-07-28 | 1.80M shares 10-Q · filed 2017-07-26 | 1.13M shares 10-Q · filed 2016-07-28 | ||||
| 2016-03-31 | 1.31M shares 10-Q · filed 2017-04-26 | 653.00K shares 10-Q · filed 2016-04-27 | ||||||
| 2015-12-31 | 922.00K shares 10-K · filed 2018-03-01 | 461.00K shares 10-K · filed 2016-02-26 | ||||||
| 2015-09-30 | 0.00 shares 10-Q · filed 2016-10-28 | 0.00 shares 10-Q · filed 2016-10-28 | ||||||
| 2015-06-30 | 477.00K shares 10-Q · filed 2016-07-28 | 268.00K shares 10-Q · filed 2016-07-28 | ||||||
| 2015-03-31 | 30.00K shares 10-Q · filed 2016-04-27 | |||||||
| 2014-09-30 | 0.00 shares 10-Q · filed 2015-11-04 | 0.00 shares 10-Q · filed 2015-11-04 | ||||||
| 2014-06-30 | 0.00 shares 10-Q · filed 2015-07-31 | 0.00 shares 10-Q · filed 2015-07-31 | ||||||
| 2014-03-31 | 0.00 shares 10-Q · filed 2015-05-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |